Variables | miR-320a expression in ovarian cancer | miR-320a expression in omentum | ||||||
---|---|---|---|---|---|---|---|---|
n | Low expression | High expression | P value | n | Low expression | High expression | P value | |
Age | Â | Â | Â | 0.691 | Â | Â | Â | 0.661 |
  ≤ 49 | 24 | 14 | 10 |  | 23 | 17 | 6 |  |
  > 49 | 39 | 26 | 13 |  | 31 | 20 | 11 |  |
Pathology | Â | Â | Â | 0.314 | Â | Â | Â | 0.023 |
 HGSOC | 46 | 27 | 19 |  | 38 | 22 | 16 |  |
 Non-HGSOC | 17 | 13 | 4 |  | 16 | 15 | 1 |  |
FIGO stage | Â | Â | Â | 0.018 | Â | Â | Â | 0.004 |
 I – II | 18 | 16 | 2 |  | 16 | 16 | 0 |  |
 III – IV | 45 | 24 | 21 |  | 38 | 21 | 17 |  |
Omentum metastasis | Â | Â | Â | 0.021 | Â | Â | Â | < 0.001 |
 Absent | 27 | 22 | 5 |  | 23 | 22 | 1 |  |
 Present | 36 | 18 | 18 |  | 31 | 15 | 16 |  |
Lymph node metastasis | Â | Â | Â | 0.033 | Â | Â | Â | 0.084* |
 Absent | 49 | 35 | 14 |  | 41 | 31 | 10 |  |
 Present | 14 | 5 | 9 |  | 13 | 6 | 7 |  |
Appendix metastasis | Â | Â | Â | 0.081* | Â | Â | Â | 0.056* |
 Absent | 52 | 36 | 16 |  | 44 | 33 | 11 |  |
 Present | 11 | 4 | 7 |  | 10 | 4 | 6 |  |